Key facts
- This page summarizes Uday Kompella's Form 4 filing for Ocugen, Inc. (OCGN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Jun 2026, 16:35.
Uday Kompella - 11 Jun 2026 Form 4 Insider Report for Ocugen, Inc. (OCGN)
- Reporting relationship
- Director
- Issuer ticker
- OCGN
- Reported as of
- 11 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2026, 16:35:06 UTC
- Prior SEC filing
- 09 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shankar Musunuri, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Uday Kompella filed Form 4 for Ocugen, Inc. (OCGN) on 15 Jun 2026.
Change
- Previous filing in this sequence was filed on 09 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001791821
Primary reporting owner
Kompella Uday
- Relationship
- Director
- Address
- C/O OCUGEN, INC., 11 GREAT VALLEY PARKWAY, MALVERN
- Signature
- /s/ Shankar Musunuri, attorney-in-fact
- Signature date
- 15 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OCGN
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +170,100
- Change %
- Price
- $0.000000*
- Shares after
- 170,100
- Date
- 11 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 170,100
- Exercise price
- $1.22
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.